This announcement replaces the 'Exercise of Options and TVR' announcement released on 14 March 2017 at 17:29 under RNS No 4752Z.
The announcement has been amended to reflect issuance of 669 Ordinary Shares not included in the figure of 24,859 from 6 March 2017.
There are no other material changes and the full amended text is shown below:
15 March 2017
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading provider of integrated veterinary services for small and large animals, announces that 24,859 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 6 March 2017 as a result of the exercise of employee share options, in connection with the Company's December 2013 - December 2016 Save As You Earn (SAYE) Scheme. A further 669 Ordinary Shares were issued on 14 March 2017 in connection with the exercise of options by a former employee under this SAYE Scheme.
The SAYE Shares rank pari passu with all existing Ordinary Shares. The admission of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2016 (the "Block Listing").
The Company also announces that 965 Ordinary Shares (the "New Shares") were issued on 14 March 2017 as a result of the exercise of employee share options by the same former employee, in connection with the Company's December 2014 - December 2017 and December 2015 - December 2018 SAYE Schemes. Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 20 March 2017.
Following issue of the New Shares and the SAYE Shares, the Company's total issued share capital will consist of 63,878,575 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 63,878,575 This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts:
CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director |
Tel: 01379 644 288 |
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Liz Yong James Hopton |
Tel: 020 7496 3000 |
